Company Filing History:
1 out of 1,187 
1 out of 111 
Years Active: 2019
Title: Innovations of Mohammad Ali Faghihi in Neurotrophic Factor Treatment
Introduction
Mohammad Ali Faghihi is an accomplished inventor based in Miami, FL. He has made significant contributions to the field of neuroscience, particularly in the treatment of brain-derived neurotrophic factor (BDNF) related diseases. His innovative approach focuses on the modulation of BDNF expression through antisense oligonucleotides.
Latest Patents
Faghihi holds a patent for the treatment of BDNF related diseases by inhibition of the natural antisense transcript to BDNF. This invention involves antisense oligonucleotides that target natural antisense polynucleotides of BDNF. The patent outlines the identification of these oligonucleotides and their potential use in treating various diseases and disorders associated with BDNF expression.
Career Highlights
Throughout his career, Faghihi has worked with notable institutions, including The Scripps Research Institute and Curna, Inc. His work has been instrumental in advancing the understanding of neurotrophic factors and their implications in neurological disorders.
Collaborations
Faghihi has collaborated with professionals in his field, including Carlos Coito, to further enhance the research and development of his innovative treatments.
Conclusion
Mohammad Ali Faghihi's contributions to the treatment of BDNF related diseases highlight his role as a significant inventor in the field of neuroscience. His innovative approaches and patented inventions pave the way for future advancements in medical treatments.